Study S000810

TIRO-AF: TIRzepatide for the Treatment of Obesity in Patients With Atrial Fibrillation

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT06802081
Acronym: TIRO-AF
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE2
Masking: TRIPLE
Status: RECRUITING
Enrollment: 100
Start: 2025-04-08
Primary completion: 2026-12-31
Lead sponsor: The Cleveland Clinic
Conditions: Atrial Fibrillation; Obesity
Interventions: DRUG:Tirzepatide; DRUG:Placebo
Results posted: FALSE
Individual participant data sharing: NO

Registered primary outcomes

AFib burden [Up to 4 weeks]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.